SARS-CoV-2 (COVID-19) nucleocapsid antibody and 1 more item

The University of Virginia awarded contract A207_PO-0455039 to Quartzy on July 7, 2026, for a cumulative contract value of $334. The prime contractor is delivering laboratory supplies and diagnostic materials to support the University of Virginia's research and testing operations. The contract encompasses two primary line items: one unit of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) nucleocapsid antibody priced at $169 per unit, and two units of Ethylenediaminetetraacetic acid (EDTA) 0.5M Solution pH 8.0 (500 milliliters) at $82.62 per unit.

Both deliverables are designated for receipt by Mary Young at the University of Virginia, the contracting organization. The contract represents a procurement of specialized biological and chemical materials commonly used in research, diagnostic testing, and laboratory workflows. No specific period of performance dates beyond the award date of July 7, 2026, are indicated in the contract documentation provided.